Tag Archives: Sanofi-Aventis

Genzyme Snubs Sanofi Offer

By George Koroneos | Published: August 31, 2010
Less than 24 hours after offering to purchase Genzyme for $18.5 billion, Sanofi-Aventis was sent a letter of rejection from the biotech firm’s board of directors stating that the offer just wasn’t worth it. “Without exception, each member of the Genzyme board believes this is not the right time to sell the company, because your opportunistic [...]
Posted in Deals | Also tagged , | Leave a comment

Pharma Unplugged #2 Layoffs & Bonuses

By George Koroneos | Published: December 7, 2009
Pharma Unplugged #2— Layoffs & Bonuses Recorded: 12/3/2009 Air Date: 12/7/2009 Host: George Koroneos, Pharm Exec Cohost: Reid Paul, Pharm Rep Magazine Show Notes: This week we discuss: Pfizer’s medical education relationship with the Canadian Medical Association Journalists take FDA to task for not being transparent enough Layoffs and job cuts at Sanofi-Aventis New report shows that DTC receives more funding than sales calls in [...]
Posted in News, Podcasts | Also tagged , , , , | Leave a comment

Pharma Industry Booming in Eastern Europe

By Amelia Tope | Published: September 2, 2009
Eastern Europe’s pharmaceutical market is forecast to grow at a CAGR of more than 10 percent to be worth more than $41 billion by 2014, according to a report from globalbusinessinsights.com. The highest sales are expected to be seen in the cardiovascular market ($7.8 billion), followed by alimentary canal and metabolic disorders ($6 billion). According to [...]
Posted in Global | Also tagged , , , , , , | Leave a comment

Latest News from ASCO: Winners, Losers, and Also Rans

By Walter Armstrong | Published: June 3, 2009
Image via Wikipedia Due to pharma’s voluntary moratorium on doling out totefuls of freebies and all the lattes you can swallow, thousands of docs, researchers, and reporters had only their sleep-deprived selves to carry from data dump to data dump at this week’s American Society of Clinical Oncology (ASCO) annual confab in Orlando, Florida. Some 4,000 studies [...]
Posted in Events | Also tagged , , , , , | 1 Comment

Sanofi Executive Change Up

By George Koroneos | Published: December 10, 2008
Barely a week after former Glaxo executive Chris Viehbacher assumed the role of CEO, Sanofi-Aventis announced that Jean-Claude Leroy, the company’s executive vp of finance and legal, has left the company. In a short statement, the company noted that his position will be filled by two people, reporting directly to Viehbacher; they are CFO [...]
Posted in People | Also tagged , , , , | Leave a comment